Towards Healthcare
Coronary Stent Market Size Envisioned at USD 12.51 Billion by 2032

Coronary Stent Market Size Envisioned at USD 12.51 Billion by 2032

The report covers Coronary Stent Market Size and Companies such as Biotronik SE & Co. KG, Cook, Terumo Corporation, Abbott, BD, MicroPort Scientific Corporation, B. Braun Melsungen AG, Boston Scientific Corporation and Medtronic. Segmentated by stent types, including Bare Metal Stents (BMS), Drug-eluting Stents (DES), Bioresorbable Scaffold System (BRS) and Drug-eluting Balloons (DEB). By end use, with products utilized in Hospitals & Ambulatory Surgical Centers, Specialty Clinics and other medical facilities. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Coronary Stent Market Assessment

  • Overview
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Coronary Stent Market Assessment

  • Overview
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Europe Coronary Stent Market Assessment

  • Overview
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Asia Pacific Coronary Stent Market Assessment

  • Overview
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Middle East and Africa Coronary Stent Market Assessment

  • Overview
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

South America Coronary Stent Market Assessment

  • Overview
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Company Profiles

  • Biotronik SE & Co. KG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Cook
  • Terumo Corporation
  • Abbott
  • BD
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Medtronic

Conclusion & Recommendations

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Aging population with increased CAD risk, Rising diabetes rates, a major CAD risk factor, Growing demand for minimally invasive procedures like stenting.

Asia Pacific is a high-growth market due to economic development and rising healthcare access. North America remains dominant but faces cost-effectiveness pressures. Emerging markets in South America and Middle East & Africa offer future potential.

Focus on bioresorbable stents that dissolve over time. Advancements in materials and drug delivery mechanisms for improved efficacy. Emphasis on cost-effective stents with long-term durability.

National Institute of Health, British Health Foundation and World Health Organization.